CHA
CVS icon

Carmichael Hill & Associates’s CVS Health CVS Stock Holding History

Carmichael Hill & Associates’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Hold
0
– – – 349
2024
Q2 		– Hold
0
– – – 332
2024
Q1 		– Hold
0
– – – 333
2023
Q4 		– Hold
0
– – – 186
2023
Q3 		– Hold
0
– – – 186
2023
Q2 		– Hold
0
– – – 194
2023
Q1 		– Hold
0
– – – 192
2022
Q4 		– Hold
0
– – – 171
2022
Q3 		– Hold
0
– – – 169
2022
Q2 		– Sell
-1,800
Closed -$176K – 177
2022
Q1 		$182K Hold
1,800
– – 0.08% 185
2021
Q4 		$186K Buy
1,800
+400
+29% +$37K 0.08% 191
2021
Q3 		$119K Buy
1,400
+400
+40% +$33.5K 0.06% 227
2021
Q2 		$83K Hold
1,000
– – 0.04% 267
2021
Q1 		$75K Buy
1,000
+700
+233% +$51K 0.04% 272
2020
Q4 		$20K Hold
300
– – 0.01% 469
2020
Q3 		$18K Hold
300
– – 0.01% 443
2020
Q2 		$19K Hold
300
– – 0.01% 421
2020
Q1 		$18K Hold
300
– – 0.02% 383
2019
Q4 		$22K Buy
+300
New +$21.1K 0.02% 386

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Carmichael Hill & Associates's CVS Position: Q3 2024 in Review

Carmichael Hill & Associates reduced its CVS Health (CVS) stake by 7.7% in Q3 2024, selling an estimated $11.7K and leaving 2,403 shares worth $151K. The position accounts for 0.05% of the portfolio, ranked #218.

Carmichael Hill & Associates first reported a position in CVS in Q4 2017 and has held it in 22 quarters since. The position peaked at $305K in Q1 2022. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

  • Carmichael Hill & Associates held 2,403 shares of CVS Health worth $151K as of Q3 2024.
  • Carmichael Hill & Associates sold 200 CVS Health shares in Q3 2024, an estimated $11.7K.
  • CVS Health made up 0.05% of Carmichael Hill & Associates's portfolio in Q3 2024, its #218 holding.
  • Carmichael Hill & Associates first reported a position in CVS Health in Q4 2017 and has held it in 22 quarters since.
  • Carmichael Hill & Associates's CVS Health position peaked at $305K in Q1 2022.
  • 1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Carmichael Hill & Associates's 13F filing for Q3 2024, filed 29 Oct 2024.